131 related articles for article (PubMed ID: 1904114)
1. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114
[TBL] [Abstract][Full Text] [Related]
2. [Thyrotropin-releasing hormone (TRH): Enhancement of dopamine dependent circling behavior and its own circling-inducing effect in unilateral striatal lesioned animals (author's transl)].
Fukuda N; Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):251-70. PubMed ID: 231554
[TBL] [Abstract][Full Text] [Related]
3. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
4. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):69-80. PubMed ID: 1904115
[TBL] [Abstract][Full Text] [Related]
6. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion.
Brundin P; Strecker RE; Londos E; Björklund A
Exp Brain Res; 1987; 69(1):183-94. PubMed ID: 3125059
[TBL] [Abstract][Full Text] [Related]
7. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Yamada K; Demarest KT; Moore KE
Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
[TBL] [Abstract][Full Text] [Related]
8. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice].
Miyamoto M; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793
[TBL] [Abstract][Full Text] [Related]
9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
10. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
Sharp T; Bennett GW; Marsden CA; Tulloch IF
Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
[TBL] [Abstract][Full Text] [Related]
12. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
Miyamoto M; Nagawa Y
Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
[TBL] [Abstract][Full Text] [Related]
13. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
14. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
Boldry R; Chang Y; Miller DD; Uretsky NJ
Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-independent motor behavior following microinjection of rimorphin in the substantia nigra.
Matsumoto RR; Lohof AM; Patrick RL; Walker JM
Brain Res; 1988 Mar; 444(1):67-74. PubMed ID: 2896062
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
[TBL] [Abstract][Full Text] [Related]
18. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
19. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
[TBL] [Abstract][Full Text] [Related]
20. A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats.
Miyamoto M; Narumi S; Nagai Y; Saji Y; Nagawa Y
Neuropharmacology; 1984 Jan; 23(1):61-72. PubMed ID: 6425711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
